122 related articles for article (PubMed ID: 22024657)
1. Development and validation of a liquid chromatography-tandem mass spectrometry assay for hair analysis of atomoxetine and its metabolites: Application in clinical practice.
Papaseit E; Marchei E; Mortali C; Aznar G; Garcia-Algar O; Farrè M; Pacifici R; Pichini S
Forensic Sci Int; 2012 May; 218(1-3):62-7. PubMed ID: 22024657
[TBL] [Abstract][Full Text] [Related]
2. Sweat testing for the detection of atomoxetine from paediatric patients with attention deficit/ hyperactivity disorder: application to clinical practice.
Marchei E; Papaseit E; Garcia-Algar O; Bilbao A; Farré M; Pacifici R; Pichini S
Drug Test Anal; 2013 Mar; 5(3):191-5. PubMed ID: 22991172
[TBL] [Abstract][Full Text] [Related]
3. Determination of atomoxetine and its metabolites in conventional and non-conventional biological matrices by liquid chromatography-tandem mass spectrometry.
Marchei E; Papaseit E; Garcia-Algar OQ; Farrè M; Pacifici R; Pichini S
J Pharm Biomed Anal; 2012 Feb; 60():26-31. PubMed ID: 22142618
[TBL] [Abstract][Full Text] [Related]
4. Concentrations of atomoxetine and its metabolites in plasma and oral fluid from paediatric patients with attention deficit/hyperactivity disorder.
Papaseit E; Marchei E; Farré M; Garcia-Algar O; Pacifici R; Pichini S
Drug Test Anal; 2013 Jun; 5(6):446-52. PubMed ID: 22589233
[TBL] [Abstract][Full Text] [Related]
5. Determination of atomoxetine metabolites in human plasma by liquid chromatography/tandem mass spectrometry and its application to a pharmacokinetic study.
Choi CI; Bae JW; Lee HI; Jang CG; Sohn UD; Lee SY
J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Feb; 885-886():103-8. PubMed ID: 22237133
[TBL] [Abstract][Full Text] [Related]
6. Development and validation of a liquid chromatography-mass spectrometry assay for hair analysis of methylphenidate.
Marchei E; Muñoz JA; García-Algar O; Pellegrini M; Vall O; Zuccaro P; Pichini S
Forensic Sci Int; 2008 Mar; 176(1):42-6. PubMed ID: 17980530
[TBL] [Abstract][Full Text] [Related]
7. Ultra-high-pressure liquid chromatography tandem mass spectrometry determination of antidepressant and anxiolytic drugs in neonatal meconium and maternal hair.
Pichini S; Cortes L; Marchei E; Solimini R; Pacifici R; Gomez-Roig MD; García-Algar O
J Pharm Biomed Anal; 2016 Jan; 118():9-16. PubMed ID: 26512994
[TBL] [Abstract][Full Text] [Related]
8. Ultra-high-pressure liquid chromatography tandem mass spectrometry determination of hallucinogenic drugs in hair of psychedelic plants and mushrooms consumers.
Pichini S; Marchei E; García-Algar O; Gomez A; Di Giovannandrea R; Pacifici R
J Pharm Biomed Anal; 2014 Nov; 100():284-289. PubMed ID: 25171488
[TBL] [Abstract][Full Text] [Related]
9. Identification and quantification of 11-nor-Δ9-tetrahydrocannabinol-9-carboxylic acid glucuronide (THC-COOH-glu) in hair by ultra-performance liquid chromatography tandem mass spectrometry as a potential hair biomarker of cannabis use.
Pichini S; Marchei E; Martello S; Gottardi M; Pellegrini M; Svaizer F; Lotti A; Chiarotti M; Pacifici R
Forensic Sci Int; 2015 Apr; 249():47-51. PubMed ID: 25659366
[TBL] [Abstract][Full Text] [Related]
10. Population Pharmacokinetic Analysis of Atomoxetine and its Metabolites in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder.
Cheng S; Al-Kofahi M; Leeder JS; Brown JT
Clin Pharmacol Ther; 2024 May; 115(5):1033-1043. PubMed ID: 38117180
[TBL] [Abstract][Full Text] [Related]
11. Atomoxetine in the treatment of attention deficit hyperactivity disorder and suicidal ideation.
Capuano A; Scavone C; Rafaniello C; Arcieri R; Rossi F; Panei P
Expert Opin Drug Saf; 2014 Sep; 13 Suppl 1():S69-78. PubMed ID: 25171160
[TBL] [Abstract][Full Text] [Related]
12. Determination of atomoxetine levels in human plasma using LC-MS/MS and clinical application to Chinese children with ADHD based on CPIC guidelines.
Xia Y; Guo HL; Hu YH; Long JY; Chen J; Chen F; Ji X
Anal Methods; 2021 Jun; 13(21):2434-2441. PubMed ID: 33998618
[TBL] [Abstract][Full Text] [Related]
13. Osmotic Release Oral System Methylphenidate Versus Atomoxetine for the Treatment of Attention-Deficit/Hyperactivity Disorder in Chinese Youth: 8-Week Comparative Efficacy and 1-Year Follow-Up.
Su Y; Yang L; Stein MA; Cao Q; Wang Y
J Child Adolesc Psychopharmacol; 2016 May; 26(4):362-71. PubMed ID: 26779845
[TBL] [Abstract][Full Text] [Related]
14. Effects of CYP2C19 genetic polymorphisms on atomoxetine pharmacokinetics.
Choi CI; Bae JW; Lee YJ; Lee HI; Jang CG; Lee SY
J Clin Psychopharmacol; 2014 Feb; 34(1):139-42. PubMed ID: 24346747
[TBL] [Abstract][Full Text] [Related]
15. Atomoxetine versus placebo in children and adolescents with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder: a double-blind, randomized, multicenter trial in Germany.
Dittmann RW; Schacht A; Helsberg K; Schneider-Fresenius C; Lehmann M; Lehmkuhl G; Wehmeier PM
J Child Adolesc Psychopharmacol; 2011 Apr; 21(2):97-110. PubMed ID: 21488751
[TBL] [Abstract][Full Text] [Related]
16. Comparative treatment patterns, healthcare resource utilization and costs of atomoxetine and long-acting methylphenidate among children and adolescents with attention-deficit/hyperactivity disorder in Germany.
Greven P; Sikirica V; Chen YJ; Curtice TG; Makin C
Eur J Health Econ; 2017 Sep; 18(7):893-904. PubMed ID: 27817164
[TBL] [Abstract][Full Text] [Related]
17. Development and validation of a stability-indicating RP-HPLC method for determination of atomoxetine hydrochloride in tablets.
Patel SK; Patel NJ
J AOAC Int; 2010; 93(4):1207-14. PubMed ID: 20922953
[TBL] [Abstract][Full Text] [Related]
18. Systematic evidence synthesis of treatments for ADHD in children and adolescents: indirect treatment comparisons of lisdexamfetamine with methylphenidate and atomoxetine.
Roskell NS; Setyawan J; Zimovetz EA; Hodgkins P
Curr Med Res Opin; 2014 Aug; 30(8):1673-85. PubMed ID: 24627974
[TBL] [Abstract][Full Text] [Related]
19. An LC-MS/MS method for the simultaneous determination of 15 antipsychotics and two metabolites in hair and its application to rat hair.
Sim J; Kim E; Yang W; Woo S; In S
Forensic Sci Int; 2017 May; 274():91-98. PubMed ID: 28111036
[TBL] [Abstract][Full Text] [Related]
20. Effects of the CYP2D6*10 allele on the pharmacokinetics of atomoxetine and its metabolites.
Byeon JY; Kim YH; Na HS; Jang JH; Kim SH; Lee YJ; Bae JW; Kim IS; Jang CG; Chung MW; Lee SY
Arch Pharm Res; 2015 Nov; 38(11):2083-91. PubMed ID: 26254792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
